Studies showed that NSC74859 and stattic, two inhibitors of STAT3, enhanced radiosensitivity by inhibiting hypoxia- and radiation-induced STAT3 activation in esophageal cancer (121, 122). Here, STAT3 is linked to esophageal cancer.